HER2 Support Group Forums - View Single Post

MJo · 08-31-2011, 01:21 PM

Interesting. I wonder what years the data is from.

I saw a report from MD Anderson that comed parlength of survival of metastatic breast cancer patients treated at their institution in five-year increments, It found that median survival had doubled to 51 months (range 33-69 months) in 1995-2000 from a median survival of 27 months (range 21-33 months) only five years earlier.

So I wonder about Stage IVs treated in the last decade.

08-31-2011, 01:21 PM	#2
MJo Senior Member Join Date: Apr 2006 Location: Wilmington, Del. Posts: 1,126	Re: "The Median Isn't the Message" Interesting. I wonder what years the data is from. I saw a report from MD Anderson that comed parlength of survival of metastatic breast cancer patients treated at their institution in five-year increments, It found that median survival had doubled to 51 months (range 33-69 months) in 1995-2000 from a median survival of 27 months (range 21-33 months) only five years earlier. So I wonder about Stage IVs treated in the last decade. __________________ MJO IDC, Stage I, Grade 2 Oncotype DX Score 32 Her2++ E+P+, Node Neg. Lumpectomy 11/04/05 Clear Margins 3 Dose dense AC (Couldn't tolerate 4) 4 Dose dense Taxol & Herc. (Tolerated well) 36 weeks Herceptin (Could not complete one year due to decrease in MUGA score) 2 years of Arimidex, then three years of Femara Finished Femara May 2011